Molecular epidemiology of hepatitis d virus infection among injecting drug users with and without human immunodeficiency virus infection in Taiwan

Journal of Clinical Microbiology

Volumn 49, Issue 3, 2011, Pages 1083-1089

  Chang, Sui Yuan ^a,b   Yang, Chia Ling ^b   Ko, Wei Shin ^a   Liu, Wen Chun ^b   Lin, Chi Ying ^b   Wu, Cheng Hsin ^b   Su, Yi Chin ^a   Chang, Shu Fang ^a   Chen, Mao Yuan ^b   Sheng, Wang Huei ^b   Hung, Chien Ching ^b   Chang, Shan Chwen ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DRUG ABUSE; FEMALE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTING DRUG USER; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SEROPREVALENCE; TAIWAN; VIREMIA; VIRUS CARRIER; VIRUS STRAIN;

ADULT; AGED; CLUSTER ANALYSIS; COMORBIDITY; DISEASE OUTBREAKS; DRUG USERS; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS C; HEPATITIS D; HEPATITIS DELTA VIRUS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEROEPIDEMIOLOGIC STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; TAIWAN;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 79952340841     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01154-10     Document Type: Article

References (38)

1. Arribas, J. R., et al. 2005. Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain. AIDS 19:1361-1365. (Pubitemid 41800671)
2. Buti, M., et al. 1996. Chronic delta hepatitis: is the prognosis worse when associated with hepatitis C virus and human immunodeficiency virus infections? J. Med. Virol. 49:66-69.
3. Chang, S. Y., et al. 2008. Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan. J. Antimicrob. Chemother. 61:689-693.
4. Chang, S. Y., et al. 2006. Molecular epidemiology of HIV type 1 subtypes in Taiwan: outbreak of HIV type 1 CRF07-BC infection in intravenous drug users. AIDS Res. Hum. Retroviruses 22:1055-1066.
5. Chen, D. S., M. Y. Lai, and J. L. Sung. 1984. Delta agent infection in patients with chronic liver diseases and hepatocellular carcinoma - an infrequent finding in Taiwan. Hepatology 4:502-503.
6. Chen, P. J., et al. 1988. Delta infection in asymptomatic carriers of hepatitis B surface antigen: low prevalence of delta activity and effective suppression of hepatitis B virus replication. Hepatology 8:1121-1124.
7. Chen, Y. M., et al. 2006. HIV-1 CRF07-BC infections, injecting drug users, Taiwan. Emerg. Infect. Dis. 12:703-705.
8. De Luca, A., et al. 2002. Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects. Arch. Intern. Med. 162:2125-2132.
9. Dény, P. 2006. Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades? Curr. Top. Microbiol. Immunol. 307:151-171.
10. Farci, P. 2003. Delta hepatitis: an update. J. Hepatol. 39(Suppl. 1):S212-S219. (Pubitemid 37222675)
11. Housset, C., et al. 1992. Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus. Hepatology 15:578-583.
12. Jardi, R., et al. 2001. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 34:404-410.
13. Kao, J. H., P. J. Chen, M. Y. Lai, and D. S. Chen. 2002. Hepatitis D virus genotypes in intravenous drug users in Taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes. J. Clin. Microbiol. 40:3047-3049.
14. Kumar, S., K. Tamura, I. B. Jakobsen, and M. Nei. 2001. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 17:1244-1245. (Pubitemid 33735359)
15. Lee, S. D., et al. 1986. Hepatitis B and D virus infection among drug abusers in Taiwan. J. Med. Virol. 20:247-252.
16. Liaw, Y. F., K. W. Chiu, C. M. Chu, I. S. Sheen, and M. J. Huang. 1990. Heterosexual transmission of hepatitis delta virus in the general population of an area endemic for hepatitis B virus infection: a prospective study. J. Infect. Dis. 162:1170-1172.
17. Liaw, Y. F., et al. 1998. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers. Am. J. Gastroenterol. 93:354-359.
18. Lin, H. H., et al. 2006. An epidemic of HIV type I CRF07-BC infection among injection drug users in Taiwan. J. Acquir. Immune Defic. Syndr. 42:248-255.
19. Liu, J. Y., et al. 2008. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan. Clin. Infect. Dis. 46:1761-1768.
20. Modahl, L. E., and M. M. Lai. 2000. The large delta antigen of hepatitis delta virus potently inhibits genomic but not antigenomic RNA synthesis: a mechanism enabling initiation of viral replication. J. Virol. 74:7375-7380.
21. Monno, L., et al. 1991. Lack of HBV and HDV replicative activity in HBsAg-positive intravenous drug addicts with immune deficiency due to HIV. J. Med. Virol. 34:199-205.
22. Novick, D. M., et al. 1988. Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. J. Infect. Dis. 158:795-803.
23. Piyasirisilp, S., et al. 2000. A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J. Virol. 74:11286-11295. (Pubitemid 32223998)
24. Pol, S., et al. 1994. Influence of human immunodeficiency virus infection on hepatitis delta virus superinfection in chronic HBsAg carriers. J. Viral Hepat. 1:131-137. (Pubitemid 2143740)
25. Rizzetto, M., et al. 1980. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J. Infect. Dis. 141:590-602.
26. Sheng, W. H., et al. 2004. Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients infected with HIV in an area where HBV infection is hyperendemic. Clin. Infect. Dis. 38:1471-1477.
27. Sheng, W. H., et al. 2007. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study. Clin. Infect. Dis. 44:988-995.
28. Stroffolini, T., et al. 1994. Incidence and risk factors of acute Delta hepatitis in Italy: results from a national surveillance system. SEIEVA Collaborating Group. J. Hepatol. 21:1123-1126.
29. Su, C. W., et al. 2006. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Gastroenterology 130:1625-1635.
30. Su, L., et al. 2000. Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B′) recombinant strain in China. J. Virol. 74:11367-11376. (Pubitemid 32224007)
31. Sulkowski, M. S., D. L. Thomas, R. E. Chaisson, and R. D. Moore. 2000. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 283:74-80.
32. Sun, H. Y., et al. 2009. Seroprevalence of chronic hepatitis B virus infection among Taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination. Am. J. Gastroenterol. 104:877-884.
33. Thio, C. L., et al. 2002. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360:1921-1926. (Pubitemid 35472132)
34. Vallet-Pichard, A., et al. 2007. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 46:32-36. (Pubitemid 47171918)
35. Wedemeyer, H., and M. P. Manns. 2010. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat. Rev. Gastroenterol. Hepatol. 7:31-40.
36. Wu, J. C. 2006. Functional and clinical significance of hepatitis D virus genotype II infection. Curr. Top. Microbiol. Immunol. 307:173-186.
37. Wu, J. C., et al. 1995. Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D. Lancet 346:939-941.
38. Wu, J. C., et al. 1990. Sexual transmission of hepatitis D virus infection in Taiwan. Hepatology 11:1057-1061.